Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced

Diabetes

Volumn 51, Issue 8, 2002, Pages 2481-2488

  O'Brien, Bronwyn A ^a   Huang, Yongqian ^a   Geng, Xuan ^a   Dutz, Jan P ^b   Finegood, Diane T ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; LIPOCORTIN 5;

ANIMAL CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULINOMA; INTERNALIZATION; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; THYMOCYTE;

EID: 0036320896     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.8.2481     Document Type: Article

References (50)

1. Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat
2. Insulin-dependent diabetes mellitus as an autoimmune disease
3. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
4. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model
5. Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse
6. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction
7. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
8. Morphological criteria for identifying apoptosis
9. Phagocyte recognition of cells undergoing apoptosis
10. Cell death: The significance of apoptosis
11. An appetite for apoptotic cells? Controversies and challenges
12. Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse
13. Aggregation of macrophages in the tips of intestinal villi in guinea pigs: Their possible role in the phagocytosis of effete epithelial cells
14. Apoptosis and programmed cell death in immunity
15. Programmed cell death in the immune system
16. Apoptosis in autoimmune diseases
17. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease
18. Distribution of pancreatic macrophages preceding and during early insulitis in young NOD mice
19. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice
20. Aberrant macrophage cytokine production is a conserved feature among autoimmuneprone mouse strains: Elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice
21. Splenic macrophages from the NOD mouse are defective in the ability to present antigen
22. Mechanisms underlying the loss of self-tolerance in NOD mice
23. Clearance of apoptotic β-cells is reduced in neonatal autoimmune diabetes-prone rats
24. Neonatal beta-cell apoptosis: A trigger for autoimmune diabetes?
25. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice
26. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans
27. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse
28. An assay for the quantitative measurement of in vitro phagocytosis of early apoptotic thymocytes by murine resident peritoneal macrophages
29. Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure
30. Complement-dependent clearance of apoptotic cells by human macrophages
31. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages
32. No constitutive defect in phagocytosis of apoptotic cells by resident peritoneal macrophages from pre-morbid lupus mice
33. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages
34. Age-dependent alterations of peritoneal exudates macrophages in autoimmune-prone and autoimmune-resistant mouse strains
35. Gender differences in some host defense mechanisms
36. Effects of age, sex and physical exercise on the phagocytic process of murine peritoneal macrophages
37. Characteristics of long-term cultures of proliferating, mononuclear phagocytes from bone marrow
38. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor
39. Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression
40. Independent mechanisms for macrophage binding and macrophage phagocytosis of damaged erythrocytes: Evidence of receptor cooperativity
41. Opsonization of apoptotic cells: Implications for uptake and autoimmunity
42. Immune complex processing in C1q-deficient mice
43. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice
44. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
45. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo
46. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis
47. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
48. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells
49. Remnants of suicidal cells fostering systemic autoaggression: Apoptosis in the origin and maintenance of autoimmunity
50. Systemic exposure to irradiated apoptotic cells induces autoantibody production